Evotec SE header image

Evotec SE

EVT

Equity

ISIN DE0005664809 / Valor 505433

Xetra (2026-11-02)
EUR 2.81-0.35%

Evotec SE
UMushroom community rating:

star star star star star
4.29 7 votes No rating yet
NegativeNeutralPositive

About company

Evotec SE is a global drug discovery and development partnership company headquartered in Germany, specializing in providing integrated solutions to the pharmaceutical and biotechnology industries. The company leverages its extensive expertise in areas such as medicinal chemistry, biology, and data science to support the development of new therapeutics across various therapeutic areas, including neuroscience, oncology, and metabolic diseases. Evotec collaborates with a diverse range of partners, including major pharmaceutical companies, biotech firms, and academic institutions, to advance innovative drug candidates from early discovery through clinical development. In the first quarter of 2025, Evotec reported progress in strategic partnerships and the implementation of initiatives aimed at achieving sustainable and profitable growth, reinforcing its position as a key player in the biopharmaceutical landscape.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-60.2%1Y
-83.5%3Y
-93.1%5Y

Performance

60.5%1Y
69.6%3Y
61.9%5Y

Volatility

Market cap

558 M

Market cap (USD)

Daily traded volume (Shares)

617,167

Daily traded volume (Shares)

1 day high/low

8.73 / 8.45

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.29

7 votes
Performance:
starstarstarstarstar
4.29
Innovation:
starstarstarstarstar
4.29
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
3.86
Meret Jaggi
Switzerland, 30 May 2022
star star star star star
Oliver Moon
Switzerland, 30 May 2022
star star star star star
German biotech/ pharma company. Decent upside potential. Analyst buy. Good performance history. Seems good to me.
Atanas WI Atanasov
Switzerland, 30 May 2022
star star star star star

EQUITIES OF THE SAME SECTOR

Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.40%EUR 34.84
Cardinal Health Inc
Cardinal Health Inc Cardinal Health Inc Valor: 196652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.54%USD 254.33
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%USD 407.88
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%SEK 280.00
Arjo AB
Arjo AB Arjo AB Valor: 39115843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.51%SEK 35.24
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%USD 208.45
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.88%USD 9.90
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%USD 29.62
PFIZER LIMITED
PFIZER LIMITED PFIZER LIMITED Valor: 912046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.33%INR 3,637.90
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited Valor: 12029898
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.58%INR 1,768.00